Baker Brothers Advisors - TRILLIUM THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,133,000
+631.0%
1,100,000
+117.7%
0.01%
+500.0%
Q3 2019$155,000
-6.6%
505,2620.0%0.00%0.0%
Q2 2019$166,000
-50.2%
505,2620.0%0.00%
-50.0%
Q1 2019$333,000
-61.5%
505,2620.0%0.00%
-71.4%
Q4 2018$864,000
-70.5%
505,2620.0%0.01%
-63.2%
Q3 2018$2,931,000
-4.6%
505,262
-1.3%
0.02%
-17.4%
Q2 2018$3,071,000
+4.2%
511,763
+25.0%
0.02%
-8.0%
Q1 2018$2,947,000
-0.7%
409,3230.0%0.02%
-3.8%
Q4 2017$2,968,000
+39.3%
409,323
-1.1%
0.03%
+52.9%
Q3 2017$2,131,000
+17.1%
413,6970.0%0.02%
+6.2%
Q2 2017$1,820,000
-28.5%
413,6970.0%0.02%
-23.8%
Q1 2017$2,544,000
+8.9%
413,6970.0%0.02%
-8.7%
Q4 2016$2,337,000
-61.8%
413,6970.0%0.02%
-58.9%
Q3 2016$6,120,000
+221.8%
413,697
+95.3%
0.06%
+180.0%
Q2 2016$1,902,000
-2.9%
211,7920.0%0.02%
-4.8%
Q1 2016$1,959,000
-26.7%
211,7920.0%0.02%
-4.5%
Q4 2015$2,671,000
+225.3%
211,792
+236.1%
0.02%
+175.0%
Q3 2015$821,00063,0140.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders